Carcinogenesis, Vol. 22, No. 12, 2023-2031,
December 2001
© 2001 Oxford University Press
CARCINOGENESIS |
Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat
Occupational Toxicology Group, Institute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm and National Institute for Working Life, S-17184 Solna, Sweden
In previous studies we have demonstrated that the p53 response to DNA damage in preneoplastic liver lesions, referred to as enzyme-altered foci (EAF), is attenuated. In the present investigation comparative quantitative RTPCR revealed no major difference in the p53 mRNA levels in EAF and non-EAF tissue. When CoCl2 was employed to induce hypoxia-inducible factor (HIF-1
), both non-EAF and EAF hepatocytes readily accumulated p53, whereas EAF hepatocytes did not accumulate p53 upon treatment with diethylnitrosamine (DEN). The p53 response was also induced in EAF hepatocytes by the inhibitor of nuclear export, leptomycin B. An inhibitor of DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM), wortmannin, blocked the DEN-induced p53 response in non-EAF hepatocytes. Assay of kinase activity in immunoprecipitated material from EAF and non-EAF tissue revealed attenuated ATM activity in EAF. Immunohistological and western blot analysis of the level of ATM protein was in agreement with the activity measurements and no phosphorylation of Ser15 in p53 was detected in EAF tissue 24 h after a challenging dose of DEN. Taken together with previously published data, these data indicate selective attenuation of the DNA damage pathway in EAF hepatocytes. Down-regulation of DNA damage-induced and ATM-mediated phosphorylation of p53 may confer a growth advantage on EAF hepatocytes.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Paajarvi, M. Viluksela, R. Pohjanvirta, U. Stenius, and J. Hogberg TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents Carcinogenesis, January 1, 2005; 26(1): 201 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakaji, Y. Yano, T. Ninomiya, Y. Seo, K. Hamano, S. Yoon, M. Kasuga, T. Teramoto, Y. Hayashi, and H. Yokozaki IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat Carcinogenesis, March 1, 2004; 25(3): 389 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Finnberg, I. Silins, U. Stenius, and J. Hogberg Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions Carcinogenesis, January 1, 2004; 25(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
